249 related articles for article (PubMed ID: 23344974)
21. Design of BRC analogous peptides based on the complex BRC8-RAD51 and the preliminary study on the peptide structures.
Zhao D; Lu K; Liu G; Zhu H; Ma L; Qi J; Yuan L
Amino Acids; 2020 May; 52(5):831-839. PubMed ID: 32417964
[TBL] [Abstract][Full Text] [Related]
22. RAD51-associated protein 1 (RAD51AP1) interacts with the meiotic recombinase DMC1 through a conserved motif.
Dunlop MH; Dray E; Zhao W; Tsai MS; Wiese C; Schild D; Sung P
J Biol Chem; 2011 Oct; 286(43):37328-34. PubMed ID: 21903585
[TBL] [Abstract][Full Text] [Related]
23. A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition.
Trenner A; Godau J; Sartori AA
Mol Cancer Ther; 2018 Jul; 17(7):1392-1404. PubMed ID: 29654063
[TBL] [Abstract][Full Text] [Related]
24. Mass spectrometry for fragment screening.
Chan DS; Whitehouse AJ; Coyne AG; Abell C
Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
[TBL] [Abstract][Full Text] [Related]
25. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex.
Doss CG; Nagasundaram N
Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641
[TBL] [Abstract][Full Text] [Related]
26. Dissecting the Recombination Mediator Activity of BRCA2 Using Biochemical Methods.
von Nicolai C; Ehlén Å; Martinez JS; Carreira A
Methods Enzymol; 2018; 600():479-511. PubMed ID: 29458771
[TBL] [Abstract][Full Text] [Related]
27. A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor.
Lee M; Daniels MJ; Garnett MJ; Venkitaraman AR
Oncogene; 2011 Jul; 30(30):3360-9. PubMed ID: 21399666
[TBL] [Abstract][Full Text] [Related]
28. A combination of
Nagatoishi S; Yamaguchi S; Katoh E; Kajita K; Yokotagawa T; Kanai S; Furuya T; Tsumoto K
Bioorg Med Chem; 2018 May; 26(8):1929-1938. PubMed ID: 29510947
[No Abstract] [Full Text] [Related]
29. RAD51 protein ATP cap regulates nucleoprotein filament stability.
Amunugama R; He Y; Willcox S; Forties RA; Shim KS; Bundschuh R; Luo Y; Griffith J; Fishel R
J Biol Chem; 2012 Mar; 287(12):8724-36. PubMed ID: 22275364
[TBL] [Abstract][Full Text] [Related]
30. Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib.
Bagnolini G; Milano D; Manerba M; Schipani F; Ortega JA; Gioia D; Falchi F; Balboni A; Farabegoli F; De Franco F; Robertson J; Pellicciari R; Pallavicini I; Peri S; Minucci S; Girotto S; Di Stefano G; Roberti M; Cavalli A
J Med Chem; 2020 Mar; 63(5):2588-2619. PubMed ID: 32037829
[TBL] [Abstract][Full Text] [Related]
31. Biophysical screening for the discovery of small-molecule ligands.
Ciulli A
Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259
[TBL] [Abstract][Full Text] [Related]
32. The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry.
Ayoub N; Rajendra E; Su X; Jeyasekharan AD; Mahen R; Venkitaraman AR
Curr Biol; 2009 Jul; 19(13):1075-85. PubMed ID: 19540122
[TBL] [Abstract][Full Text] [Related]
33. Cancer. BRCA2 enters the fray.
Wilson JH; Elledge SJ
Science; 2002 Sep; 297(5588):1822-3. PubMed ID: 12228708
[No Abstract] [Full Text] [Related]
34. Sequence fingerprints in BRCA2 and RAD51: implications for DNA repair and cancer.
Lo T; Pellegrini L; Venkitaraman AR; Blundell TL
DNA Repair (Amst); 2003 Sep; 2(9):1015-28. PubMed ID: 12967658
[TBL] [Abstract][Full Text] [Related]
35. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.
Yang H; Jeffrey PD; Miller J; Kinnucan E; Sun Y; Thoma NH; Zheng N; Chen PL; Lee WH; Pavletich NP
Science; 2002 Sep; 297(5588):1837-48. PubMed ID: 12228710
[TBL] [Abstract][Full Text] [Related]
36. Effect of the BRCA2 CTRD domain on RAD51 filaments analyzed by an ensemble of single molecule techniques.
Holthausen JT; van Loenhout MT; Sanchez H; Ristic D; van Rossum-Fikkert SE; Modesti M; Dekker C; Kanaar R; Wyman C
Nucleic Acids Res; 2011 Aug; 39(15):6558-67. PubMed ID: 21576230
[TBL] [Abstract][Full Text] [Related]
37. Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction.
Subramanyam S; Jones WT; Spies M; Spies MA
Nucleic Acids Res; 2013 Oct; 41(19):9020-32. PubMed ID: 23935068
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of filament formation of human Rad51 protein by a small peptide derived from the BRC-motif of the BRCA2 protein.
Nomme J; Takizawa Y; Martinez SF; Renodon-Cornière A; Fleury F; Weigel P; Yamamoto K; Kurumizaka H; Takahashi M
Genes Cells; 2008 May; 13(5):471-81. PubMed ID: 18429819
[TBL] [Abstract][Full Text] [Related]
39. The molecular perspective: RAD51 and BRCA2.
Goodsell DS
Stem Cells; 2005 Oct; 23(9):1434-5. PubMed ID: 16210413
[No Abstract] [Full Text] [Related]
40. Conformational flexibility and oligomerization of BRCA2 regions induced by RAD51 interaction.
Sidhu A; Grosbart M; Sánchez H; Verhagen B; van der Zon NLL; Ristić D; van Rossum-Fikkert SE; Wyman C
Nucleic Acids Res; 2020 Sep; 48(17):9649-9659. PubMed ID: 32785644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
